| |||||||
| |||||||
| |||||||
1 | SENATE JOINT RESOLUTION
| ||||||
2 | WHEREAS, Chronic Kidney Disease is the 9th leading cause of | ||||||
3 | death in the United States; an estimated 31 million people in | ||||||
4 | the United States have chronic kidney disease; over 1.12 | ||||||
5 | million people in the State of Illinois are living with the | ||||||
6 | disease; early chronic kidney disease has no signs or symptoms | ||||||
7 | and, without early detection, can progress to kidney failure; | ||||||
8 | and
| ||||||
9 | WHEREAS, If a person has high blood pressure, heart | ||||||
10 | disease, diabetes, or a family history of kidney failure, the | ||||||
11 | risk of kidney disease is greater; in Illinois, 13% of all | ||||||
12 | adults have diabetes, and 32% have high blood pressure; the | ||||||
13 | prevalence of diabetes, heart disease, and hypertension is | ||||||
14 | higher for African Americans, who develop kidney failure at a | ||||||
15 | rate of nearly 4 to 1 compared to Caucasians, while Hispanics | ||||||
16 | develop kidney failure at a rate of 2 to 1; almost half of the | ||||||
17 | people waiting for a kidney in Illinois identify as African | ||||||
18 | American, but, in 2017, less than 10% of them received a | ||||||
19 | kidney; and
| ||||||
20 | WHEREAS, Although dialysis is a life-extending treatment, | ||||||
21 | the best and most cost effective treatment for kidney failure | ||||||
22 | is a kidney transplant; currently, the wait in Illinois for a | ||||||
23 | deceased donor kidney is 5-7 years, and, everyday, 13 people |
| |||||||
| |||||||
1 | die while waiting; and
| ||||||
2 | WHEREAS, If chronic kidney disease is detected early and | ||||||
3 | managed appropriately, the individual can receive treatment | ||||||
4 | sooner to help protect the kidneys, the deterioration in kidney | ||||||
5 | function can be slowed or even stopped, and the risk of | ||||||
6 | associated cardiovascular complications and other | ||||||
7 | complications can be reduced; therefore, be it
| ||||||
8 | RESOLVED, BY THE SENATE OF THE ONE HUNDRED FIRST GENERAL | ||||||
9 | ASSEMBLY OF THE STATE OF ILLINOIS, THE HOUSE OF REPRESENTATIVES | ||||||
10 | CONCURRING HEREIN, that the Kidney Disease Prevention and | ||||||
11 | Education Task Force is created to work directly with | ||||||
12 | educational institutions to create health education programs | ||||||
13 | to increase awareness of and to examine chronic kidney disease, | ||||||
14 | transplantations, living and deceased kidney donation, and the | ||||||
15 | existing disparity in the rates of those afflicted between | ||||||
16 | Caucasians and minorities; and be it further | ||||||
17 | RESOLVED, That the Task Force will also be expected to | ||||||
18 | develop a sustainable plan to raise awareness about early | ||||||
19 | detection, promote health equity, and reduce the burden of | ||||||
20 | kidney disease throughout the State, which should include an | ||||||
21 | ongoing campaign that would include health education workshops | ||||||
22 | and seminars, relevant research, and preventative screenings, | ||||||
23 | and promote social media campaigns and TV and radio |
| |||||||
| |||||||
1 | commercials; and be it further | ||||||
2 | RESOLVED, That membership of the Task Force shall be as | ||||||
3 | follows: | ||||||
4 | (1) One member of the Senate, appointed by the Senate | ||||||
5 | President, who shall serve as Co-Chair; | ||||||
6 | (2) One member of the House of Representatives, | ||||||
7 | appointed by the Speaker of the House, who shall serve as | ||||||
8 | Co-Chair; | ||||||
9 | (3) One member of the House of Representatives, | ||||||
10 | appointed by the Minority Leader of the House; | ||||||
11 | (4) One member of the Senate, appointed by the Senate | ||||||
12 | Minority Leader; | ||||||
13 | (5) One member representing the Department of Public | ||||||
14 | Health, appointed by the Governor; | ||||||
15 | (6) One member representing the Department of | ||||||
16 | Healthcare and Family Services, appointed by the Governor; | ||||||
17 | (7) One member representing a medical center in a | ||||||
18 | county with a population of more 3 million residents, | ||||||
19 | appointed by the Co-Chairs; | ||||||
20 | (8) One member representing a physician's association | ||||||
21 | in a county with a population of more than 3 million | ||||||
22 | residents, appointed by the Co-Chairs; | ||||||
23 | (9) One member representing a not-for-profit organ | ||||||
24 | procurement organization, appointed by the Co-Chairs; | ||||||
25 | (10) One member representing a national non-profit |
| |||||||
| |||||||
1 | research kidney organization in the State of Illinois, | ||||||
2 | appointed by the Co-Chairs; and | ||||||
3 | (11) The Secretary of State or his or her designee; and | ||||||
4 | be it further | ||||||
5 | RESOLVED, That members of the Task Force shall serve | ||||||
6 | without compensation; and be it further | ||||||
7 | RESOLVED, That the Department of Public Health shall | ||||||
8 | provide administrative support to the Task Force; and be it | ||||||
9 | further | ||||||
10 | RESOLVED, That the Task Force shall submit its final report | ||||||
11 | to the General Assembly on or before December 31, 2020 and, | ||||||
12 | upon the filing of its final report, is dissolved.
|